Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
Thyroid : Official Journal of the American Thyroid Association|April 16, 2014
Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescenceStephanie Markovina, Perry W Grigsby, Julie K Schwarz, et al.Cancer Medicine|December 16, 2018
A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancerAlexander J Lin, Pamela Samson, Todd DeWees, et al.Medical Physics|March 6, 2014
Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancerHua Li, Beth Bottani, Todd DeWees, et al.Gynecologic Oncology|February 16, 2016
Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapyAnupama Chundury, Anthony Apicelli, Todd DeWees, et al.Practical Radiation Oncology|June 17, 2018
Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedulePamela Samson, Sana Rehman, Aditya Juloori, et al.Brachytherapy|May 24, 2017
Which patients with inoperable vulvar cancer may benefit from brachytherapy in addition to external beam radiation? A Surveillance, Epidemiology, and End Results analysisYuan James Rao, Caressa Hui, Anupama Chundury, et al.Journal of Magnetic Resonance Imaging : JMRI|October 2, 2012
Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervixJeffrey R Olsen, Jacqueline Esthappan, Todd DeWees, et al.Journal of Radiation Oncology|February 25, 2014
Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinomaAdam A Garsa, Albert J Chang, Todd Dewees, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2017
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomenLauren Henke, Rojano Kashani, Clifford Robinson, et al.Clinical and Translational Radiation Oncology|September 12, 2022
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trialJ Isabelle Choi, Kiran Prabhu, William F Hartsell, et al.Pageof 7